Acrivon Therapeutics, Inc.

Historical 13F Holders

Symbol
ACRV
CUSIP
004890109
All holders as of
Q3 2026
Type
Equity
Class
COMMON STOCK
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 004890109 since 12/18/2024, largest first.

Filer % of Class Filed
RA Capital Management, L.P. 13D/A
28.8% 4/23/2026
Event 4/22/2026
Sands Capital Life Sciences Pulse Fund II, L.P. 13G/A
5.3% 8/13/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Citadel Advisors LLC 13G/A
0% 5/15/2026
Event 3/31/2026
Perceptive Advisors LLC 13G/A
0% 6/4/2025
Event 6/2/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 47 21.2 M $43.4M
2026 Q2 46 21.4 M $38.1M
2026 Q1 44 16.2 M $22.6M
2025 Q4 49 18.6 M $44.9M
2025 Q3 48 17.5 M $32.7M
2025 Q2 54 17.8 M $21.2M
2025 Q1 64 22.5 M $45.7M
2024 Q4 64 23.3 M $140M
2024 Q3 56 23.0 M $161M
2024 Q2 56 23.5 M $136M
2024 Q1 49 15.2 M $109M
2023 Q4 43 15.3 M $74.5M
2023 Q3 44 15.1 M $144M
2023 Q2 41 15.1 M $196M
2023 Q1 40 15.2 M $191M
2022 Q4 19 15.0 M $170M